Produktbild: Drug Adherence and Therapeutic Inertia in Chronic Diseases
Vorbesteller Neu

Drug Adherence and Therapeutic Inertia in Chronic Diseases DE

Fr. 171.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

03.10.2026

Herausgeber

Michel Burnier

Verlag

Springer

Seitenzahl

300

Maße (L/B)

23.5/15.5 cm

Sprache

Englisch

ISBN

978-3-032-29570-5

Beschreibung

Portrait

Michel Burnier is Emeritus Professor of Medicine and former Head of the Division of Nephrology and Hypertension at the University Hospital of Lausanne, Switzerland. He is Invited Professor at the Medical University of Gdańsk, Poland, and trained in internal medicine and nephrology in Lausanne and at the University of Colorado Health Sciences Center in Denver. He is a member of the Scientific Council of the European Society of Hypertension and has served as President of both the Swiss Society of Nephrology and the Swiss Society of Hypertension. Professor Burnier is Editor‑in‑Chief of Blood Pressure . His research focuses on renal mechanisms of hypertension and the progression of chronic kidney disease, with particular emphasis on sodium. He has also contributed extensively to antihypertensive pharmacology—especially therapies targeting the renin–angiotensin system—and to medication adherence research. His work has been recognised with the JM Métry Compliance Award (ESPACOMP) and the Peter van Zwieten and Paul Milliez awards and Björn Folkow Award of the European Society of Hypertension.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

03.10.2026

Herausgeber

Michel Burnier

Verlag

Springer

Seitenzahl

300

Maße (L/B)

23.5/15.5 cm

Sprache

Englisch

ISBN

978-3-032-29570-5

Herstelleradresse

Springer International Publishing AG
Gewerbestr. 11
6330 Cham
Schweiz
Url: www.springer.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Drug Adherence and Therapeutic Inertia in Chronic Diseases
  • Clinical inertia: definition and current landscape in Europe.- Management of adherence by healthcare professionals across Europe: insights from COST Action ENABLE.- Real world studies using nationwide registries to assess determinants of medication adherence.- Medication adherence in hypertension: a Polish example.- Adherence in patients with high pill burden - the example of nephrology.- Are there common pathways explaining medical inertia and nonadherence?.- Psychological Determinants of Hypertension and Drug Adherence: The Role of Alexithymia, Emotional Dysregulation and Trauma.- Training and medical education influence on adherence.- Transformative Treatment Paradigm Shift for Adaptive Adherence Measures and Patient‑Focused Recovery.- Renal denervation as a treatment option in patients with non-adherence to antihypertensive medications.- Very long acting drugs and long-term persistence to medications.- Single-pill combination and adherence to prescribed treatment in cardiovascular risk reduction.- Strategies to support adherence to lifestyle recommendations.- How to detect poor adherence in clinical practice.- Benefits and Limitations of Chemical Adherence Testing (CAT).- Electronic Monitoring of Medication Adherence.- Smart monitoring for smart control: the role of cuffless wearable in the hypertension management.- Physician adherence to the study protocol in hypertension outcome trials (“investigator inertia”).- Recommendations for the measurement, analysis and reporting of adherence in clinical trials.- Is It Possible to Perform a Randomized Controlled Trial on Drug Adherence?.- How can pharmacist collaboration support medication adherence?.- The role of nurses in the management of adherence.- "Team-based care as an approach to improve medication adherence and persistence".- Could “Omics” Help to Improve Adherence?.- Vascular Age for risk communication -  a joint approach in pharmacies and primary care: the TOGETHER trial.- Can Innovative Solutions Solve the Problem of Adherence?.- Conclusions and perspectives.